Pellagra is a disease caused primarily by niacin (nicotinic acid) deficiency and characterised by the classical triad of dermatitis, diarrhoea and dementia. A niacin deficiency state can be brought about by various causes, such as inadequate food intake, malabsorption syndrome, increased requirement or administration of drugs which interfere with niacin synthesis. Tuberculous patients may develop pellagra, owing to an increase in niacin requirement and isonicotinic acid hydrazide (isoniazid) therapy. Isoniazid is a widely used, highly effective antituberculous drug. It has a structural formula similar to niacin. Isoniazid interferes with the conversion of tryptophan to niacin, by producing a deficiency in the pyridoxine coenzymes required for the conversion. Therefore, isoniazid may induce various manifestations of pellagra, particularly in poorly nourished patients. There are several reports of isoniazid-induced pellagra, based on clinical grounds; 1-6 however, to our knowledge, no necropsy study has been published.
We found eight cases showing neuropathological features of pellagra among 106 necropsy cases of tuberculous patients. These eight patients had pre-no past history of alcoholic psychosis nor any other men disease. He abstained from drinking and started to ta isoniazid 04 g daily, p-amino-salicylic acid (PAS) 1( daily and streptomycin 1-0 g im twice weekly, at a tube culous sanatorium as an out-patient. In June 1967 began to show a disturbance of gait and was admitted the sanatorium on 15 August. By mid-September became confined to bed with paraparesis and incontinen of both urine and faeces, and showed evidence of men disturbance. He was transferred to Kurate Kyoritsu Hosl tal from the sanatorium on 26 Skin lesions were observed in four cases. Case 2 presented typical symmetrical pellagra dermatitis on the exposed parts of the body. On the first occasion, it was cured by multi-vitamin tablets including niacin. But on the second episode of pellagra dermatitis, which resulted in the patient's death because pellagra was not suspected clinically, no treatment was undertaken. In case 3 the skin pigmentation was thought to be due to Addison's disease by an attending physician. At necropsy there was no adrenal abnormality. In case 7, facial lesions were described as dyssebacia and eczema-like dermatitis on the chart. These lesions were possibly features of pellagra dermatitis, because they are seen in those who have been bedridden for a period of time. In case 8, pigmentation, rough and scally lesions were noted.
Laboratory data examined in the terminal stage of the illness were insufficient. However, there were indications of malnutrition. Anaemia (a haemoglobin below 70%) was seen in six cases. Four cases had hypoproteinaemia (serum protein less than 6-0 g/dl). Lumbar (fig 4) . Pathologically, the immediate cause of death was thought to be bronchopneumonia in six cases. But in two cases the direct cause of death was uncertain, other than pellagra. The livers were unremarkable, except for case 8, which clinically had increased transaminase, exhibited histological features consistent with drug induced hepatitis.
Among the 106 cases of tuberculosis, there were five others showing slight to moderate chromatolytic changes in Betz cells and pontine nuclei. However, they did not present any clinical features suggestive of pellagra, such as mental, neurological and gastrointestinal symptoms or skin lesions. Therefore, they were excluded from the present pellagra group. Two of them were patients with senile dementia of Alzheimer type.
Discussion
Only four of these eight cases had skin lesions which were highly suggestive of pellagra dermatitis, but were not so diagnosed. None had the diagnosis confirmed by biochemical methods (excretion of N'-methylnicotinamide etc). However, we are convinced that these eight cases had pellagra" on the following neuropathological and clinical grounds. The most consistent neuropathological change in pellagra is said to be central chromatolysis. The distribution of the chromatolytic neurons in our eight cases was similar to those reported by many authors.7-Although the histological picture of pellagra glossitis (as of pellagra dermatitis) is nonspecific, the presence of glossitis confirmed histologically in seven out of eight cases is in agreement with the diagnosis. Emaciation and laboratory data suggestive of malnutrition were also in favour of pellagra.
-The mental symptoms observed in the eight patients were insomnia, anxiety, depression, neurasthenia, apathy, confusion, hallucination and delirium. All of these symptoms may occur in endemic and alcoholic pellagrins.7'-6 However, the mental symptoms were considered to be those of schizophrenia or schizophrenic reaction in six cases. McConnell and Cheetham' reported a 22-year-old male who developed acute pellagra with skin, gastrointestinal and various mental symptoms during isoniazid therapy. A psychiatrist who saw this patient reported that he was suffering from a schizophrenic reaction which presented many catatonic features. Shah'3 Neurological symptoms of pellagra are also characteristic.'" Leigh'°collected 14 necropsy cases of pellagra, among whom spastic paraplegia was noted in three cases. We reported 20 necropsy cases of alcoholic pellagra. '5 Gait disturbance, extrapyramidal rigidity and hyperreflexia of the legs, incontinence of urine and faeces were observed in the majority of the cases. Polyneuropathy and seizure were also noted in some cases. Jolliffe et al '6 listed cogwheel rigidity of the extremities as one of the characteristic neurological features. Our present eight cases showed gait disturbance, spasticity of the legs and incontinence in almost all the cases, as well as polyneuropathy, facial myoclonus, seizure and dysphagia in some cases. These neurological symptoms are not diagnostic of, but are consistent with pellagra.
Isoniazid has a structural formula similar to niacin and nicotinamide. Nicotinamide functions as the component of two important coenzymes, NAD (nicotinamide adenine dinucleotide) and NADP (nicotinamide adenine dinucleotide phosphate), which are functional groups in intracellular oxidation reduction enzyme systems necessary for tissue respiration, glycolysis, and fat synthesis. In nicotinamide deficiency states, such as poorly nourished patients or chronic tuberculous patients, cells may incorporate the structurally similar isoniazid for the formation of NAD and NADP which then does not function as a coenzyme and may lead to the development of pellagra.5 But this theory is not likely. It is known that isoniazid intake produces pyridoxine deficiency which leads to a disturbance of normal tryptophan metabolism to niacin. '8 There are several case reports of isoniazidinduced pellagra. '-6 In all of these cases pellagra dermatitis is described. Some demonstrate mental and neurological symptoms, such as confusional psychosis, schizophrenic reaction, increased tone in the legs. On the other hand, cases are reported of isoniazid-induced encephalopathy. ' Before the advent of isoniazid, Ying-K'uei9 noticed that diarrhoea, tuberculosis and malnutrition were the outstanding clinical features among the necropsy cases of pellagra. Biehl and Vilter27 found that, with daily doses of 5 mg per kg body weight, neurological side-effects occurred in only 2% of patients, but with a daily dose of 6-10 mg per kg the incidence rose to 10% and with 11-15 mg it went up to 20%. Our eight cases had tuberculosis, malnutrition and overdose of isoniazid as compared with their body weight. The isoniazid daily doses ranged from 7-7 mg to 13*3 mg per kg. Case 2 had had ethionamide 0-3 g per day along with isoniazid, prior to the first episode of pellagra. Ethionamide (ethyl-thio-isonicotinamide) is a derivative of isoniazid and might also inhibit niacin synthesis.
Pellagra is now considered to be a disappearing disease, particularly in the developed countries. However, the disease is still occasionally observed among chronic alcoholics, food faddists, patients with malabsorptive disease of the gastrointestinal tract and with malignant carcinoid. It may also be seen in patients treated with chemotherapeutic agents which inhibit tryptophan metabolism or antagonise one of the vitamins associated with this pathway, such as isoniazid, thiosemicarbasone derivatives, 6-Mercaptopurine, 5-fluorouracil and puromycin. 28 Still" wrote that pellagra sine pelle agra still lies hidden and unsuspected in the mortality data of mental hospitals. We should not forget pellagra, an easily curable disease, in such patients.
